Entera Bio Ltd. WT EXP 06...

NASDAQ: ENTXW · Real-Time Price · USD
0.00
-0.00 (-100.00%)
At close: Jun 27, 2023, 8:42 PM

Entera Bio WT EXP 062723 Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
8.66M 11.02M 12.31M 24.89M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
86K 6K 96K 46K
Receivables
126K n/a 246K 183K
Inventory
n/a n/a -294K n/a
Other Current Assets
186K 238K 294K 254K
Total Current Assets
8.97M 11.26M 12.85M 25.33M
Property-Plant & Equipment
332K 488K 139K 395K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
418K 508K 278K 658K
Total Assets
9.39M 11.77M 13.13M 25.99M
Account Payables
132K 83K 17K 166K
Deferred Revenue
n/a n/a 43K 15K
Short-Term Debt
170K n/a 91K 179K
Other Current Liabilities
874K 500K 842K 2.03M
Total Current Liabilities
1.18M 1.09M 1.34M 3.16M
Long-Term Debt
102K n/a n/a 123K
Other Long-Term Liabilities
32K 32K 32K 15K
Total Long-Term Liabilities
134K 288K 32K 261K
Total Liabilities
1.31M 1.38M 1.37M 3.42M
Total Debt
272K 390K 91K 302K
Book Value
n/a n/a n/a n/a
Book Value Per Share
n/a n/a n/a n/a
Common Stock
1K 1K n/a n/a
Retained Earnings
-113.93M -104.39M -95.5M -82.43M
Comprehensive Income
41K 41K 41K 41K
Shareholders Equity
8.08M 10.39M 11.75M 22.57M
Total Investments
n/a n/a n/a n/a